Remdesivir expected to remain effective against omicron variant, Gilead says

Remdesivir targets the viral RNA polymerase in order to prevent replication of SARS-CoV-2 inside infected cells. In addition to genetic analyses, Gilead continues to evaluate remdesivir through in vitro antiviral testing.

from Google Alert - Business https://ift.tt/3xKw00r
Remdesivir targets the viral RNA polymerase in order to prevent replication of SARS-CoV-2 inside infected cells. In addition to genetic analyses, Gilead continues to evaluate remdesivir through in vitro antiviral testing. https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize